Ying Fu
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: South China Agricultural University (2016–2020); Beijing Institute of Technology (2025); Brigham and Women's Hospital (1998); Ford Foundation (2016); Universiti Sains Malaysia (2024); Central South University (2017); Nanchang University (2020–2024); Northwestern Polytechnical University (2006–2020); Shanghai Jiao Tong University (2005–2025); Georgetown University (2015); Guangdong University of Foreign Studies (2024); South China Normal University (2009–2011); Bloomsburg University (2017); Chengde Medical University (2024–2025); Chinese Academy of Sciences (2013–2023); Hainan University (2023–2024); Ministry of Natural Resources (2021); Fudan University (2025); China University of Mining and Technology (2021–2022); Wenzhou Medical University (2008); Discovery Institute (2024); Georgetown University Medical Center (2015); Australian Regenerative Medicine Institute (2024–2025); Sir Run Run Shaw Hospital (2012–2025); Chang Gung Memorial Hospital (2025); First Affiliated Hospital of Jiangxi Medical College (2024); Zhejiang Provincial Institute of Communications Planning,Design & Research (2025); Key Laboratory of Guangdong Province (2016–2018); Research Support Instruments (United States) (2025); People's Liberation Army No. 150 Hospital (2025); Seva Mandir (2016); Shenzhen Center for Disease Control and Prevention (2025); Shanghai Cancer Institute (2017); Chengde Medical University (2024–2025); Beijing Luhe Hospital Affiliated to Capital Medical University (2017–2021); Linkou Chang Gung Memorial Hospital (2025); Dana-Farber Cancer Institute (1998); Zhejiang Environmental Monitoring Center (2024–2025); Yunnan Water Conservancy and Hydropower Survey and Design Institute (2024); Institute of Microbiology (2020–2023); State Key Laboratory of Oncogene and Related Genes (2017); Third Affiliated Hospital of Zhengzhou University (2025); Shenzhen Luohu People's Hospital (2023–2025); Ministry of Water Resources of the People's Republic of China (2021); Zhejiang Taizhou Hospital (2008); Institute of Geographic Sciences and Natural Resources Research (2013–2014); Qilu Hospital of Shandong University (2016–2023); Dana-Farber Brigham Cancer Center (1998); Zhejiang Medicine (China) (2025); Shanghai Institute of Pharmaceutical Industry (2024); University of Chinese Academy of Sciences (2013–2014); First Affiliated Hospital Zhejiang University (2015); PRG S&Tech (South Korea) (2025); Huazhong University of Science and Technology (2009–2012); Zhejiang University of Technology (2022–2024); Monash University (2024–2025); Ocean University of China (2005); The University of Tokyo (2025); Zhejiang University (2012–2025); Southwestern University (2024); University of Oklahoma (2018–2024); Capital Normal University (2015–2017)
Faculty Researcher
Upstream record may be merged OpenAlex, the source of these figures, lists 63 institutions in 7 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ying Fu is a faculty member at the University of Arkansas at Fayetteville with a research focus that spans microbial ecology, antibiotic resistance, and the mechanobiology of cellular processes. Fu's work investigates the factors influencing microbial diversity in soil, including the impact of climate warming and nutrient availability, and explores the role of specific metabolites in linking soil microbiomes and plant rhizospheres. This research is supported by multiple federal grants from the National Institutes of Health (NIH), totaling over $1.4 million, which fund investigations into mechanobiology, cell sorting based on contractility, and the dissection of genetic variation underlying complex traits in model organisms.
Fu has co-authored publications on the evolution of antibiotic resistance in hypervirulent bacterial strains, such as *Klebsiella pneumoniae*, and the identification of resistance mechanisms using advanced technologies like plasmonic nanosensors and machine learning. The researcher's scholarly output includes 197 publications, with an h-index of 34 and over 4,000 citations, indicating a significant contribution to their fields. Collaborations include work with Xiaolun Sun and Tahrir Alenezi from the University of Arkansas at Fayetteville, among others, highlighting an active research network.
Metrics
- h-index: 34
- Publications: 197
- Citations: 4,296
Selected Publications
-
The Mechanistic Target of Rapamycin Mediates Clostridium perfringens-Induced Chicken Necrotic Enteritis Attenuated by Secondary Bile Acid Deoxycholic Acid (2025)
-
Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence (2024)
Federal Grants 5 $1,433,308 total
Investigating the mechanobiology of multicellular morphogenesis
Decoding Gene-Environment Interactions in Complex Traits via Multi-Omics Approaches
Dissecting cryptic genetic variation underlying complex traits in Drosophila
Developing branch stress microscopy for the mechanobiology of 3D morphogenesis and invasive diseases
Collaboration Network
Top Collaborators
- Clostridium perfringens-Induced Necrotic Diseases: An Overview
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
- Clostridium perfringens-Induced Necrotic Diseases: An Overview
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
Similar Researchers
Based on overlapping research topics